Skip to main content
March 23, 2026/3 min read

Accretion/ Dilution

Evaluate M&A Deal Impact on Shareholder Value

Key Purpose

Accretion/dilution analysis serves as a fundamental screening tool to determine whether a proposed merger or acquisition will increase or decrease earnings per share for the acquiring company's shareholders.

  • An accretion/dilution analysis serves as the fundamental litmus test for evaluating whether a proposed merger or acquisition creates immediate shareholder value
  • This critical analysis determines whether the post-transaction earnings per share (EPS) will increase (accretion) or decrease (dilution) for the acquiring company's shareholders
  • Deal architects must navigate a complex web of considerations including negotiation dynamics, regulatory landscapes, cultural integration challenges, and strategic compatibility between organizations
  • The analytical framework begins with constructing pro-forma financial statements to model the combined entity's earning power and share structure
  • The resulting pro-forma EPS comparison against standalone metrics reveals whether the transaction enhances or diminishes per-share value creation

While accretion/dilution analysis provides essential insights into immediate EPS impact, sophisticated dealmakers recognize it represents just one dimension of value creation. Strategic benefits, market positioning, and long-term synergy realization often justify transactions that appear dilutive in year one but generate substantial returns over time.

Steps for Accretion / Dilution Analysis

  1. Construct pro-forma net income by combining both entities' earnings, incorporating realistic synergy estimates and integration costs
  2. Determine the combined company's total share count, accounting for both existing shareholders and any newly issued equity
  3. Calculate the acquirer's adjusted share count, factoring in new shares issued for stock consideration, convertible securities, and employee stock compensation
  4. Compute pro-forma EPS by dividing the combined net income by the total pro-forma share count

The mathematical outcome is straightforward: an EPS increase signals accretion, while a decrease indicates dilution. However, the real art lies in the assumptions underlying these calculations.

Before presenting your analysis, subject every assumption to rigorous scrutiny. Apply professional skepticism particularly to projected synergies—history shows that 70% of deals fail to achieve their anticipated cost savings and revenue enhancements. Conservative estimates often prove more valuable than optimistic projections that derail post-merger integration.

Accretion / Dilution Calculation

Target and Acquirer net income

Calculate = EPS × outstanding share count

Synergies and Integration Costs

Benchmark against comparable transactions and apply haircuts to management estimates

Pro-forma net income

Combined entities + net synergies - additional interest expense (all after-tax)

New shares issued

Calculate = total equity consideration ÷ acquirer's share price

Remember that in today's market environment, with elevated interest rates and increased regulatory scrutiny on large transactions, the bar for deal approval has risen significantly. Your accretion/dilution analysis must demonstrate compelling value creation to satisfy both internal stakeholders and external observers who will scrutinize every aspect of the proposed transaction.

Key Takeaways

1Accretion/dilution analysis is a fundamental screening tool for evaluating M&A transactions based on their impact on earnings per share
2The analysis involves calculating pro forma net income and share count to determine if the transaction increases or decreases EPS
3Accretive transactions increase EPS while dilutive transactions decrease EPS, though dilutive deals may still create long-term strategic value
4Key calculation steps include estimating combined net income, factoring in synergies, and determining new share count for stock deals
5Professional skepticism is essential when evaluating projected synergies, as many deals fail to achieve expected benefits
6The formula involves dividing pro forma net income by pro forma shares, with new shares calculated as equity issued divided by acquirer share price
7Managers must consider broader factors beyond just accretion/dilution including negotiation dynamics, global impact, and company compatibility
8Quality control through verification of calculations and conservative synergy estimates is crucial for reliable analysis results

RELATED ARTICLES